• Perphenazine Beyond Dopamine: A Translational View

  2026-08-20

  Perphenazine is more than a dopamine D2 receptor antagonist: its multi-receptor pharmacology, mitochondria-mediated cell death induction, opioid tolerance suppression, and emerging host-directed antibacterial activity create a valuable translational research framework. This article connects receptor biology with neuronal, immune, and disease-model evidence while defining practical workflow safeguards and the limits of current interpretation.

• 3-Bromopyruvate Reverses Cetuximab Resistance in CRC

  2026-08-20

  This 2023 Cancer Gene Therapy study shows that combining 3-bromopyruvate with cetuximab can suppress colorectal cancer cells that are intrinsically or adaptively resistant to cetuximab. The work links restored FOXO3a activity to coordinated autophagy, ferroptosis, and apoptosis, providing a mechanistic framework for studying treatment resistance rather than treating it as a single-pathway problem.

• Hepatic sEH, Nrf2, and Osteoporosis

  2026-08-19

  A 2025 pre-proof study identifies a liver–bone axis in osteoporosis in which hepatic soluble epoxide hydrolase alters circulating 14,15-EET and 14,15-DHET, suppressing Nrf2 signaling and promoting osteoclastogenesis. By combining patient samples, ovariectomy-induced mice, liver-specific sEH knockdown, pharmacological inhibition, and transcriptomics, the work provides a mechanistic framework for studying redox imbalance and fatty acid epoxide signaling in bone loss.

• Merbromin for Fluorescence and Protease Assays

  2026-08-19

  Merbromin is a versatile biochemical research fluorescent dye that connects protein-binding spectroscopy with enzyme inhibition and antimicrobial screening. Its static-quenching behavior, mercury-containing structure, and adsorption sensitivity also make rigorous controls essential for reliable assay interpretation.

• GLT-1, CB1-CREB Signaling, and TBI Cognition

  2026-08-18

  A 2025 Biomolecules study identifies a mechanistic link between post-traumatic endocannabinoid signaling, reduced astrocytic GLT-1, glutamate excitotoxicity, and cognitive dysfunction. Using pharmacological manipulation and behavioral, biochemical, and histological analyses in mice, the authors show that CB1 blockade preserves GLT-1 expression and attenuates neuronal apoptosis after traumatic brain injury.

• CGP 55845 Hydrochloride for Synaptic Assays

  2026-08-18

  CGP 55845 hydrochloride provides a selective way to separate GABAB receptor signaling from astrocytic GAT-3 effects in dentate gyrus experiments. This workflow-focused guide shows how to use concentration-ranging, electrophysiology, and pharmacological controls to improve neurotransmitter release modulation and synaptic transmission research.

• Metoprolol Tartrate: Precision β1 Blockade

  2026-08-17

  Metoprolol Tartrate is a selective β1-adrenergic blocking agent for mechanistic cardiovascular research. New evidence distinguishing β1 from nonselective β-blockade in hematopoietic regeneration provides a strategic framework for model selection, controls, and translational interpretation.

• Cediranib and the Logic of Drug-Response Assays

  2026-08-17

  Cediranib (AZD2171) offers a powerful model for separating VEGFR pathway engagement from true cancer-cell killing. This article translates Schwartz’s drug-response framework into a rigorous assay strategy for angiogenesis and cancer research.

• Perphenazine: From D2 Signaling to Host Defense

  2026-08-16

  Perphenazine is a dopamine D2 receptor antagonist with a pharmacology that connects neuronal signaling, mitochondrial injury, and macrophage host defense. This article provides a mechanistic framework for designing and interpreting assays across neuropharmacology and intracellular infection research.

• YAP–TEAD Control of Surface Ectoderm Commitment

  2026-08-15

  Wang and colleagues map how super-enhancers regulate early surface ectoderm commitment from pluripotent stem cells and identify YAP–TEAD as an activating transcriptional module. By combining three-dimensional genome profiling, CRISPR-dCas9 perturbation, and transcription-factor experiments, the study connects enhancer architecture with causal control of lineage progression and epithelial regeneration.

• Perphenazine: Applied Neuroimmune Workflows

  2026-08-15

  Perphenazine is a dopamine D2 receptor antagonist that supports complementary neuropharmacology, mitochondrial toxicity, opioid tolerance, and host-directed antibacterial workflows. Its multi-receptor profile makes it valuable for pathway discovery, provided dose, vehicle, ROS, autophagy, and cytotoxicity controls are built into the experiment.

• Griseofulvin Workflows for Microtubule Research

  2026-08-14

  Griseofulvin provides a practical mechanistic probe for studying fungal cell mitosis, microtubule disruption, and antifungal response phenotypes. This workflow connects solvent handling and dose optimization with orthogonal imaging, cell-cycle, and aneugenicity assays for more reproducible research decisions.

• EdU Flow Cytometry Assay Kits (Cy5)

  2026-08-14

  A scenario-based guide to using EdU Flow Cytometry Assay Kits (Cy5), SKU K1078, for precise S-phase DNA synthesis measurement and multiplexed flow cytometry. It addresses assay design, click chemistry, controls, interpretation, and practical vendor selection for proliferation, genotoxicity, and pharmacodynamic studies.

• EdU Imaging Kits (HF594) in Resistance Biology

  2026-08-13

  EdU Imaging Kits (HF594) provide a precise DNA synthesis measurement strategy for studying treatment-resistant adenocarcinoma. This article explains how to interpret EdU signals as pharmacodynamic evidence, distinguish cytostasis from toxicity, and integrate imaging with flow cytometry and pathway analysis.

• Iptacopan (LNP023): From Target to PNH Assay

  2026-08-13

  Iptacopan (LNP023) connects selective factor B pharmacology with clinically meaningful PNH biomarkers. This assay-centered guide explains how to translate alternative pathway C3bBb inhibition into rigorous complement activation research.

448 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page